Develops mRNA-based epigenetic reprogramming medicines for age-related conditions via its ERA platform, with an early focus on skin.
Biotech using cellular reprogramming to restore cell health and reverse aspects of aging, injury, and disease.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →